Previous Article | Next Article ![]()
Applied and Environmental Microbiology, July 2001, p. 3280-3284, Vol. 67, No. 7
Department of Entomology, University of
California, Riverside, California 92521,1 and
Bactéries et Champignons Entomopathogènes,
Institute Pasteur, Paris, France2
Received 17 November 2000/Accepted 2 April 2001
The interaction of two cytolytic toxins, Cyt1Ab from
Bacillus thuringiensis subsp. medellin
and Cyt2Ba from Bacillus thuringiensis subsp.
israelensis, with Bacillus sphaericus was
evaluated against susceptible and resistant Culex
quinquefasciatus and the nonsensitive species Aedes
aegypti. Mixtures of B. sphaericus with either
cytolytic toxin were synergistic, and B. sphaericus
resistance in C. quinquefasciatus was suppressed from
>17,000- to 2-fold with a 3:1 mixture of B. sphaericus
and Cyt1Ab. This trait may prove useful for combating insecticide
resistance and for improving the activity of microbial insecticides.
The pathogenic toxins produced by
mosquitocidal strains of Bacillus thuringiensis belong to
two structurally distinct groups, the crystal (Cry) Cyt1Aa is found in the parasporal crystal of B. thuringiensis subsp. israelensis enveloped with three
other mosquitocidal crystal toxins: Cry4A, Cry4B, and Cry11A. Cyt1Aa
represents approximately 40% of the protein in the parasporal crystal,
whereas each of the three crystal toxins represents about 20% of the
remaining protein (17). The toxicity of the individual
proteins is lower than the toxicity of the intact parasporal body, and
these toxins interact synergistically to produce high mosquitocidal
activity (8, 17, 27, 39).
The interaction among the cytolytic and crystal toxins has been
implicated as a major factor in the lack of resistance to B. thuringiensis subsp. israelensis in laboratory and
field-selected mosquitoes (3, 4, 11, 12, 14). Experiments
revealed that resistance could be readily induced in mosquitoes that
were selected with single or multiple crystal toxins but not in
mosquitoes selected with the native mixture of crystal and cytolytic
toxins in B. thuringiensis subsp. israelensis
(13). Cross-resistance testing of the Cry4- and/or
Cry11A-resistant colonies revealed that the selected
colonies remained susceptible to B. thuringiensis subsp.
israelensis (35). It was subsequently shown
that combinations of Cyt1Aa and Cry4 and/or Cry11A toxins from B. thuringiensis subsp. israelensis suppressed resistance
due to higher levels of synergism against the resistant mosquitoes
compared to susceptible mosquitoes (36).
Recently it was shown that sublethal concentrations of Cyt1Aa combined
with Bacillus sphaericus suppressed B. sphaericus
resistance (38). B. sphaericus is an unrelated,
mosquitocidal bacterium that produces a binary toxin with molecular
masses of 52 and 43 kDa, which are the binding and toxin domains,
respectively (2, 6). This same mixture proved to be highly
toxic toward Aedes aegypti, a mosquito species that is not
normally susceptible to B. sphaericus because it lacks a
specific receptor for the binary toxin (23). The high
activity in both cases resulted from synergism (34, 38).
The interaction of Cyt1Aa with crystal Lyophilized powders of spore-crystal mixtures were used in all tests.
Technical powder of B. sphaericus (strain 2362) was obtained
from Abbott Laboratories (North Chicago, Ill.). Cyt1Ab1 (31) and Cyt2Ba (15) were separately produced
in a nontoxic strain of B. thuringiensis subsp.
thuringiensis. Both strains were grown on UG medium
(9); the sporulated cells were washed once in 1 M NaCl and
twice in distilled water and centrifuged, and the pellets were
lyophilized. Densitometry was used to estimate the amount of toxin
protein in the cytolytic toxin preparations from sodium dodecyl
sulfate-polyacrylamide gel electrophoresis, using Alpha Ease Version
3.24 (Alpha Innotech Corporation, San Leandro, Calif.) and CA-Cricket
Graph III (Computer Associates International, Inc., Islandia, N.Y.).
The toxin protein concentration of the Cyt2Ba was estimated to be 0.063 mg/mg of powder. The density of the Cyt1Ab band was on average
1.96-fold greater than that of the Cyt2Ba band (average of three
replicates; standard deviation = 0.063 mg), yielding an estimated
Cyt1Ab protein concentration of 0.123 mg/mg of powder. For testing,
stock suspensions of the powders were prepared in distilled water with
glass beads and agitated using a vortex mixer. Stocks were prepared
monthly, and 10-fold serial dilutions were prepared weekly. All stocks
and dilutions were stored at Groups of early fourth instars were exposed to a range of
concentrations of the spore-crystal powders in 100 ml of distilled water in 237-ml plastic cups. The range usually included 8 to 12 different concentrations that caused mortality of between 2 and 98%,
as well as controls. Bioassays were replicated on five different days,
with 100 larvae exposed to each concentration. The toxin powder
combinations were tested at two proportions, 3:1 and 10:1 (B. sphaericus to cytolytic toxin), based on the dry weight of each
powder. Mortality was evaluated at 24 and 48 h.
All data were evaluated using a probit program (10, 28).
Lethal concentrations with overlapping fiducial limits were not considered to be significantly different. Resistance ratios were calculated by dividing the lethal concentration of the resistant colony
(Bs-R) by that of the susceptible colony (Syn-P). Synergism factors
(SF) were calculated as described by Tabashnik (30). The
SF is the ratio of the expected 50% lethal concentration
(LC50) or LC95 of the toxin
mixture to the observed LC50 or
LC95, respectively. The expected
LC50 or LC95 was calculated
from the weighted harmonic mean of the individual values for the
toxins. An SF value of greater than 1 indicated a synergistic
interaction between the components in the mixture.
These tests showed that for C. quinquefasciatus, powders of
Cyt2Ba were more toxic to the susceptible (Syn-P) and resistant (Bs-R)
strains than was Cyt1Ab, despite the higher concentration by weight of
Cyt1Ab toxin in the powders (Table 1).
Although the difference was not statistically significant, both
cytolytic toxins were more active toward the Bs-R strain than toward
the Syn-P strain.
0099-2240/01/$04.00+0 DOI: 10.1128/AEM.67.7.3280-3284.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
Cyt1Ab1 and Cyt2Ba1 from Bacillus
thuringiensis subsp. medellin and B.
thuringiensis subsp. israelensis Synergize
Bacillus sphaericus against Aedes
aegypti and Resistant Culex
quinquefasciatus (Diptera: Culicidae)
![]()
ABSTRACT
Top
Abstract
Text
References
![]()
TEXT
Top
Abstract
Text
References
-endotoxins,
which are the predominant type, and the cytolytic (Cyt)
-endotoxins
(16). These crystal and cytolytic
-endotoxins are
generally toxic to mosquito larvae, although to various degrees, and
are believed to act through the formation of pores in the midgut
epithelium by colloid-osmotic lysis (18). The cytolytic
toxins are structurally unrelated to the crystal toxins and lyse cells
in vitro. Several cytolytic toxins have been identified in
mosquitocidal strains of B. thuringiensis, including Cyt1Aa
and Cyt2Ba1 from B. thuringiensis subsp.
israelensis (15, 33), Cyt2Aa1 from B. thuringiensis subsp. kyushuensis (19),
Cyt1Ab1 from B. thuringiensis subsp. medellin
(31), and Cyt2Bb1 from B. thuringiensis subsp.
jegathesan (7). Of these cytolytic toxins, only
Cyt1Aa has been extensively evaluated.
-endotoxins and its capacity
to suppress resistance to B. thuringiensis subsp.
israelensis and B. sphaericus and to extend the
host range of B. sphaericus raise the possibility that other
cytolytic
-endotoxins may have similar traits. To learn more about
the mode of action of cytolytic toxins, we tested Cyt1Ab1 from B. thuringiensis subsp. medellin and Cyt2Ba1 from B. thuringiensis subsp. israelensis, alone or in
combination with B. sphaericus, against B. sphaericus-resistant (strain Bs-R) (37) or B. sphaericus-susceptible (strain Syn-P) (38)
Culex quinquefasciatus and against A. aegypti
(34).
20°C when not in use.
TABLE 1.
Toxicities of B. sphaericus, Cyt1Ab, Cyt2Ba,
and combinations of B. sphaericus and Cyt1Ab or Cyt2Ba
toward susceptible (strain Syn-P) and B. sphaericus-resistant (strain Bs-R) C. quinquefasciatus
When B. sphaericus was combined with Cyt2Ba or Cyt1Ab at either ratio, the mixtures were highly toxic and generally interacted synergistically (Table 1). SF values ranged from 2.2 to >10,000 after 24 h of exposure and were orders of magnitude higher against the resistant Bs-R (23 to 10,900) than against the susceptible Syn-P (2.2 to 60). SF values were generally lower after 48 h of exposure, and these values ranged from 0.2 to 24.5 and from 0.08 to 996 for Syn-P and Bs-R, respectively.
The cytolytic toxin concentration affected the SF values but not the lethal concentrations (LC50 or LC95). For example, lethal concentrations were generally not significantly different when Cyt1Ab was presented at a 3:1 versus a 10:1 ratio. However, SF values, particularly for Bs-R, were affected by the difference in toxin concentration; values were higher at a 3:1 ratio. Lethal concentrations were lower after 48 h than after 24 h of exposure. This effect was more pronounced at the LC50.
The most toxic combination was a 3:1 mixture of B. sphaericus and Cyt1Ab. After 48 h of exposure, the LC50 against Bs-R was 0.132 µg/ml, and this combination suppressed resistance from >17,000-fold to 2-fold. This represents a 7,500-fold improvement in toxicity toward Bs-R. This same mixture was also more toxic toward Syn-P at the LC50 (0.00326 µg/ml) but was not significantly different at the LC95.
Consistent with previous reports, B. sphaericus was
relatively nontoxic toward A. aegypti (20, 22)
(Table 2). The Cyt2Ba powder was
significantly more toxic than Cyt1Ab against A. aegypti, as
observed for C. quinquefasciatus. When B. sphaericus was combined with either cytolytic toxin, toxicity was
greatly enhanced. For example, the LC95 of
B. sphaericus was
34,000 µg/ml. However, a 10:1 mixture
of B. sphaericus and Cyt1Ab exhibited an
LC95 of 4.75 µg/ml, a 7,100-fold increase in
toxicity. Combinations of B. sphaericus with Cyt1Ab were
more toxic than combinations with Cyt2Ba. The enhanced toxicity for all
combinations tested against A. aegypti resulted from
synergism between B. sphaericus and the cytolytic toxins. SF
values ranged from 2.6 to 1,930 for combinations with Cyt1Ab and from
1.3 to 7.1 for combinations with Cyt2Ba.
|
The results reported here for Cyt1Ab and Cyt2Ba are consistent with previous work with Cyt1Aa from B. thuringiensis subsp. israelensis. In those studies, Cyt1Aa suppressed high levels of B. sphaericus resistance in C. quinquefasciatus (38) and broadened the spectrum of activity to A. aegypti when combined with B. sphaericus (34). Thus, all three cytolytic toxins from B. thuringiensis tested to date have the capacity to synergize B. sphaericus against resistant mosquitoes and to enhance toxicity against A. aegypti. However, unlike Cyt1Aa, which was not synergistic when combined with B. sphaericus and tested against susceptible C. quinquefasciatus, both Cyt1Ab and Cyt2Ba interacted synergistically with B. sphaericus. This observation is particularly interesting because Cyt1Aa and Cyt1Ab are highly homologous (31). The amino acid differences between Cyt1Aa and Cyt1Ab toxins may provide some important clues to the mechanism of synergism of cytolytic toxins.
Although Cyt2Ba was more toxic per milligram of protein than Cyt1Ab, mixtures of B. sphaericus and Cyt1Ab were more acutely toxic and resulted in higher SF values than Cyt2Ba. These high SF values resulted from the low toxicity of Cyt1Ab, as lethal concentrations for the toxin mixtures were generally not significantly different against the same mosquito strain.
Our data differ from those of Thiéry et al. (32), who reported no increase in toxicity against susceptible Culex pipiens and A. aegypti for a recombinant strain expressing both B. sphaericus 2297 and Cyt1Ab. However, increased toxicity was observed when this recombinant strain was tested against two B. sphaericus-resistant colonies, including our Bs-R strain. These differences may be due to the two strains of B. sphaericus involved (2362 versus 2297) or to the proportion of Cyt1Ab relative to B. sphaericus. Their recombinant strain expressed a 1:2 ratio of B. sphaericus to Cyt1Ab (32). Although the precise ratio of toxins in our tests is not known, Cyt1Ab was presented at a lower proportion than the B. sphaericus binary toxin.
Recombinant bacterial strains that combine B. sphaericus toxins with crystal and/or cytolytic toxins from B. thuringiensis have been developed. Some of these strains showed enhanced toxicity against A. aegypti and/or against B. sphaericus-resistant C. pipiens complex (1, 21, 25, 26, 29, 32), while others did not (5, 32). Although the increased toxicity observed with some of these recombinants was attributed to synergistic interactions, no definitive evidence of synergism was provided. The present study and previous work with Cyt1Aa (34, 38) provide substantial evidence that synergism is an important component of the increased toxicity of mixtures of B. sphaericus and cytolytic toxins.
The mechanism of this synergism is still not known. Because A. aegypti naturally lacks a receptor for B. sphaericus (23) and the Bs-R mosquitoes are resistant because their midgut no longer binds the B. sphaericus binary toxin (24), cytolytic toxins may promote the binding or insertion of the B. sphaericus binary toxins. Further work on the mechanism of toxicity of cytolytic toxins and their interaction with mosquitocidal toxins is needed. Regardless of these unresolved questions, cytolytic toxins may be extremely useful in expanding the host range of B. sphaericus and in overcoming resistance to this material in C. quinquefasciatus.
| |
ACKNOWLEDGMENTS |
|---|
The help of Hyun-Woo Park is gratefully acknowledged.
This research was supported by the University of California Mosquito Control Research Program.
| |
FOOTNOTES |
|---|
* Corresponding author. Mailing address: Department of Entomology, University of California, Riverside, CA 92521. Phone: (909) 787-3918. Fax: (909) 787-3086. E-mail: mcwirth{at}mail.ucr.edu.
| |
REFERENCES |
|---|
|
|
|---|
| 1. | Bar, E., N. Sandler, M. Makayoto, and A. Keynan. 1998. Expression of chromosomally inserted Bacillus thuringiensis israelensis toxin genes in Bacillus sphaericus. J. Invert. Pathol. 72:206-213[CrossRef][Medline]. |
| 2. |
Baumann, P.,
M. A. Clark,
L. Baumann, and A. H. Broadwell.
1991.
Bacillus sphaericus as a mosquitocidal pathogen: properties of the organism and its toxins.
Microbiol. Rev.
55:425-436 |
| 3. | Becker, N. 1997. Microbial control of mosquitoes: management of the Upper Rhine mosquito population as a model programme. Parasitol. Today 13:485-487. |
| 4. | Becker, N., and M. Ludwig. 1993. Investigations on possible resistance in Aedes vexans field populations after a 10-year application of Bacillus thuringiensis israelensis. J. Am. Mosq. Control Assoc. 9:221-224[Medline]. |
| 5. |
Bourgouin, C.,
A. Delécluse,
F. de la Torre, and J. Szulmajster.
1990.
Transfer of the toxin protein genes of Bacillus sphaericus into Bacillus thuringiensis subsp. israelensis and their expression.
Appl. Environ. Microbiol.
56:340-344 |
| 6. | Charles, J.-F., C. Nielsen-LeRoux, and A. Delécluse. 1996. Bacillus sphaericus toxins; molecular biology and mode of action. Annu. Rev. Entomol. 41:451-472[CrossRef][Medline]. |
| 7. |
Cheong, H., and S. S. Gill.
1997.
Cloning and characterization of a cytolytic and mosquitocidal -endotoxin from Bacillus thuringiensis subsp. jegathesan.
Appl. Environ. Microbiol.
63:3254-3260[Abstract].
|
| 8. |
Crickmore, N.,
E. J. Bone,
J. A. Williams, and D. J. Ellar.
1995.
Contribution of the individual components of the -endotoxin crystal to the mosquitocidal activity of Bacillus thuringiensis subsp. israelensis.
FEMS Microbiol. Lett.
131:249-254[CrossRef].
|
| 9. | de Barjac, H., and M.-M. Lecadet. 1976. Dosage biochimique de l'exotoxine thermostable de B. thuringiensis d'apres l'inhibition d'ARN-polymerases bacteriennes. C. R. Acad. Sci (Paris) 282:2119-2122. |
| 10. | Finney, D. 1971. Probit analysis. Cambridge University Press, Cambridge, United Kingdom. |
| 11. | Georghiou, G. P. 1990. Resistance potential to biopesticides and consideration of countermeasures, p. 409-420. In J. E. Casida (ed.), Pesticides and alternatives. Elsevier Science Publishers, New York, N.Y. |
| 12. | Georghiou, G. P., M. C. Wirth, J. Ferrari, and H. Tran. 1991. Baseline susceptibility and analysis of variability toward biopesticides in California populations of Culex quinquefasciatus., p. 25-27. In Annual Report of the University of California Mosquito Control Research Program. University of California, Oakland. |
| 13. | Georghiou, G. P., and M. C. Wirth. 1997. Influence of exposure to single versus multiple toxins of Bacillus thuringiensis subsp. israelensis on development of resistance in the mosquito Culex quinquefasciatus (Diptera: Culicidae). Appl. Environ. Microbiol. 63:1095-1101[Abstract]. |
| 14. | Goldman, I. F., J. Arnold, and B. C. Carlton. 1986. Selection for resistance to Bacillus thuringiensis subsp. israelensis in field and laboratory populations of the mosquito Aedes aegypti. J. Invert. Pathol. 47:317-324[CrossRef][Medline]. |
| 15. | Guerchicoff, A., R. A. Ugalde, and C. P. Rubenstein. 1997. Identification and characterization of a previously undescribed cyt gene in Bacillus thuringiensis subsp. israelensis. Appl. Environ. Microbiol. 63:2716-2721[Abstract]. |
| 16. |
Höfte, H., and H. Whitely.
1989.
Insecticidal crystal proteins of Bacillus thuringiensis.
Microbiol. Rev.
53:242-255 |
| 17. |
Ibarra, J., and B. A. Federici.
1986.
Isolation of a relatively nontoxic 65-kilodalton protein inclusion from the parasporal body of Bacillus thuringiensis subsp. israelensis.
J. Bacteriol.
165:527-533 |
| 18. |
Knowles, B. H., and D. J. Ellar.
1987.
Colloid-osmotic lysis is a general mechanism of action of Bacillus thuringiensis -endotoxins with different insect specificity.
Biochim. Biophys. Acta
924:509-518.
|
| 19. |
Koni, P., and D. J. Ellar.
1994.
Biochemical characterization of Bacillus thuringiensis cytolytic -endotoxins.
Microbiology
140:1869-1880[Abstract].
|
| 20. | Lacey, L. A., and S. Singer. 1982. Lavicidal activity of new isolates of Bacillus sphaericus and Bacillus thuringiensis (H-14) against anopheline and culicine mosquitoes. Mosq. News 42:537-543. |
| 21. | Li, T., F. Sun, Z. Yuan, Y. Zhang, J. Yu, and Y. Pang. 2000. Coexpression of cyt1Aa of Bacillus thuringiensis subsp. israelensis with Bacillus sphaericus binary toxin gene in acrystalliferous strain of B. thuringiensis. Curr. Microbiol. 40:322-326[CrossRef][Medline]. |
| 22. | Mulla, M. S., H. A. Darwazeh, E. W. Davidson, H. T. Dulmage, and S. Singer. 1984. Larvicidal activity and field efficacy of Bacillus sphaericus strains against mosquito larvae and their safety to nontarget organisms. Mosq. News 44:336-342. |
| 23. | Nielsen-LeRoux, C., and J.-F. Charles. 1992. Binding of Bacillus sphaericus binary toxin to a specific receptor on midgut brush-border membranes from mosquito larvae. Eur. J. Biochem. 210:585-590[Medline]. |
| 24. | Nielsen-LeRoux, C., J.-F. Charles, I. Thiéry, and G. P. Georghiou. 1995. Resistance in a laboratory population of Culex quinquefasciatus (Diptera: Culicidae) to Bacillus sphaericus binary toxin is due to a change on midgut brush-border membranes. Eur. J. Biochem. 228:206-210[Medline]. |
| 25. | Poncet, S., C. Bernard, E. Dervyn, J. Cayley, A. Klier, and G. Rapoport. 1997. Improvement of Bacillus sphaericus toxicity against dipteran larvae by integration, via homologous recombination, of the cry11A gene from Bacillus thuringiensis subsp. israelensis. Appl. Environ. Microbiol. 63:4413-4420[Abstract]. |
| 26. | Poncet, S., A. Delécluse, G. Anello, A. Klier, and G. Rapoport. 1994. Transfer and expression of the cryIVB and cryIVD genes of Bacillus thuringiensis subsp. israelensis in Bacillus sphaericus 2297. FEMS Microbiol. Lett. 117:91-96[CrossRef]. |
| 27. | Poncet, S., A. Delécluse, A. Klier, and G. Rapoport. 1994. Evaluation of synergistic interactions among CryIVA, CryIVB, and CryIVD toxic components of Bacillus thuringiensis subsp. israelensis crystals. J. Invert. Pathol. 66:131-135. |
| 28. | Raymond, M., G. Prato, and D. Ratsira. 1993. Probability analysis of mortality assays displaying quantal response, version 3.3. Praxeme, Saint Georges D'Orques, France. |
| 29. |
Servant, P.,
M.-L. Rosso,
S. Hamon,
S. Poncet,
A. Delécluse, and G. Rapoport.
1999.
Production of Cry11A and Cry11Ba toxins in Bacillus sphaericus confers toxicity towards Aedes aegypti and resistant Culex populations.
Appl. Environ. Microbiol.
65:3021-3026 |
| 30. |
Tabashnik, B. E.
1992.
Evaluation of synergism among Bacillus thuringiensis toxins.
Appl. Environ. Microbiol.
58:3343-3346 |
| 31. | Thiéry, I., A. Delécluse, M. C. Tamayo, and S. Orduz. 1997. Identification of a gene for a Cyt1A-like hemolysin from Bacillus thuringiensis subsp. medellin and expression in a crystal-negative Bacillus thuringiensis strain. Appl. Environ. Microbiol. 63:468-473[Abstract]. |
| 32. |
Thiéry, I.,
S. Hamon,
A. Delécluse, and S. Orduz.
1998.
The introduction into Bacillus sphaericus of the Bacillus thuringiensis subsp. medellin cyt1Ab1 gene results in higher susceptibility of resistant mosquito larva populations to B. sphaericus.
Appl. Environ. Microbiol.
64:3910-3916 |
| 33. |
Waalwijk, C.,
A. M. Dullemans,
M. E. S. von Workman, and B. Visser.
1985.
Molecular cloning and nucleotide sequence of the Mr 28,000 crystal protein gene of Bacillus thuringiensis subsp. israelensis.
Nucleic Acids Res.
13:8207-8217 |
| 34. |
Wirth, M. C.,
B. A. Federici, and W. E. Walton.
2000.
Cyt1A from Bacillus thuringiensis subsp. israelensis synergizes activity of Bacillus sphaericus against Aedes aegypti (Diptera: Culicidae).
Appl. Environ. Microbiol.
66:1093-1097 |
| 35. | Wirth, M. C., and G. P. Georghiou. 1997. Cross-resistance among CryIV toxins of Bacillus thuringiensis subsp. israelensis in Culex quinquefasciatus (Diptera: Culicidae). J. Econ. Entomol. 90:1471-1477. |
| 36. |
Wirth, M. C.,
G. P. Georghiou, and B. A. Federici.
1997.
CytA enables CryIV endotoxins of Bacillus thuringiensis to overcome high levels of CryIV resistance in the mosquito, Culex quinquefasciatus.
Proc. Natl. Acad. Sci. USA
94:10536-10540 |
| 37. | Wirth, M. C., G. P. Georghiou, J. I. Malik, and G. H. Abro. 2000. Laboratory selection for resistance to Bacillus sphaericus in Culex quinquefasciatus (Diptera: Culicidae) from California, USA. J. Med. Entomol. 37:534-540[Medline]. |
| 38. | Wirth, M. C., W. E. Walton, and B. A. Federici. 2000. Cyt1A from Bacillus thuringiensis subsp. israelensis restores toxicity of Bacillus sphaericus against resistant Culex quinquefasciatus (Diptera: Culicidae). J. Med. Entomol. 37:401-407[Medline]. |
| 39. | Wu, D., and F. N. Chang. 1985. Synergism in mosquitocidal activity of 26 and 65 kDa proteins from Bacillus thuringiensis subsp. israelensis crystal. FEBS Lett. 190:232-236[CrossRef]. |
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| J. Bacteriol. | Microbiol. Mol. Biol. Rev. | Eukaryot. Cell | All ASM Journals |
|---|